| Chronic Myeloid Leukemia, BCR-ABL1 Positive investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 118show all (up to 200) |
|---|
| → investigated in trials for | Fludarabinesmall molecule 71 trials (14 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall_molecule 56 trials (8 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 54 trials (16 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall_molecule 48 trials (10 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall_molecule 47 trials (8 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 23 trials (3 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall_molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 20 trials (5 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 20 trials (7 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 20 trials (4 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall_molecule 19 trials (2 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 17 trials (5 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asciminibsmall_molecule 11 trials (7 active) · roll-up of the cancer and its descendants | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 11 | Observed | clinicaltrials | graph → |